Related references
Note: Only part of the references are listed.Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: Current state-of-the science
Ibrahim Halil Sahin et al.
CANCER LETTERS (2014)
Prognostic Relevance of Number and Ratio of Metastatic Lymph Nodes in Resected Pancreatic, Ampullary, and Distal Bile Duct Carcinomas
Ewa Pomianowska et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Intestinal-type and Pancreatobiliary-type Adenocarcinomas: How Does Ampullary Carcinoma Differ from Other Periampullary Malignancies?
Arne Westgaard et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Histomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of Vater
David K. Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Gene Expression Profiling of Ampullary Carcinomas Classifies Ampullary Carcinomas into Biliary-Like and Intestinal-Like Subtypes That Are Prognostic of Outcome
Michael J. Overman et al.
PLOS ONE (2013)
Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma
Giuseppe Aprile et al.
TUMOR BIOLOGY (2013)
Role of cyclooxygenase-2 in gastric cancer development and progression
Jian Cheng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Non-steroid anti-inflammatory drugs, prostaglandins, and cancer
Viola Allaj et al.
CELL AND BIOSCIENCE (2013)
Resection margin involvement and tumour origin in pancreatic head cancer
C. S. Verbeke et al.
BRITISH JOURNAL OF SURGERY (2012)
Reclassification of tumour origin in resected periampullary adenocarcinomas reveals underestimation of distal bile duct cancer
E. Pomianowska et al.
EJSO (2012)
Cell Intrinsic Role of COX-2 in Pancreatic Cancer Development
Reginald Hill et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Cyclooxygenase-Deficient Pancreatic Cancer Cells Use Exogenous Sources of Prostaglandins
Noriyuki Omura et al.
MOLECULAR CANCER RESEARCH (2010)
The role of COX-2 in intestinal inflammation and colorectal cancer
D. Wang et al.
ONCOGENE (2010)
Comparative analysis of clinicopathological correlations of cyclooxygenase-2 expression in resectable pancreatic cancer
Marketa Hermanova et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours
Arne Westgaard et al.
HISTOPATHOLOGY (2009)
Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast
Min Hua et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor
Arne Westgaard et al.
BMC CANCER (2008)
Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma
Arne Westgaard et al.
BMC CANCER (2008)
Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions
Marketa Hermanova et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2008)
Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression
Jennifer K. Colby et al.
NEOPLASIA (2008)
Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer
Hiroyuki Matsubayashi et al.
CANCER BIOLOGY & THERAPY (2007)
Quantification of immunohistochemistry - issues concerning methods, utility and semiquantitative assessment I
R. A. Walker
HISTOPATHOLOGY (2006)
COX-2 expression of ampullary carcinoma:: correlation with different histotypes and clinicopathological parameters
Giuseppe Perrone et al.
VIRCHOWS ARCHIV (2006)
Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice
Karin Mueller-Decker et al.
GASTROENTEROLOGY (2006)
Cyclooxygenase-2 expression in hamster and human pancreatic neoplasia
Pamela L. Crowell et al.
NEOPLASIA (2006)
Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer
A Juuti et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients
D Santini et al.
CLINICAL CANCER RESEARCH (2005)
The role of prostaglandins and other eicosanoids in the gastrointestinal tract
DZ Wang et al.
GASTROENTEROLOGY (2005)
Cyclooxygenase-2 expression associated with severity of PanIN lesions: A possible link between chronic pancreatitis and pancreatic cancer
R Albazaz et al.
PANCREATOLOGY (2005)
Expression of cyclooxygenase-2 in cholangiocarcinoma: Correlation with clinicopathological features and prognosis
HJ Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
TD Warner et al.
FASEB JOURNAL (2004)
PGE2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells
G Eibl et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Expression of cyclooxygenase-2 and its correlation with clinicopathologic factors of ampulla of Vater cancer
HJ Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2003)
Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia - An immunohistochemical analysis with automated cellular imaging
A Maitra et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2002)
Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer
G Kong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Cyclooxygenases and colon cancer
N Kawai et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Cyclo-oxygenase-2 expression in primary cancers of the lung and bladder compared to normal adjacent tissue
CJ Sweeney et al.
CANCER DETECTION AND PREVENTION (2002)
Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters
K Merati et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2001)
Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder
A Ristimäki et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Cyclooxygenase-2 expression in human pancreatic adenocarcinomas
MT Yip-Schneider et al.
CARCINOGENESIS (2000)